REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/01/2026
Back to search
Official data from USPTO
LYMPHOQUANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPHOQUANT
ST13
US500000087588377Class
1, 5, 42, 44
Filing
87588377
Registration
6373233
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
06/02/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
08/29/2017
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/08/2019
First use in commerce
09/08/2019
Drawing code
4
Owner type
03
Owner location
SAN DIEGO, CA, US
Examiner
CLARK, ROBERT C
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
INVIVOSCRIBE, INC.
Invivoscribe Technologies, Inc.
Representatives
Sarah W. Matthews Dentons Durham Jones Pinegar
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific and research usebuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for researchclinical researchlaboratory research use
Class 5
Assays for the treatment or diagnosis of disease; medical diagnostic reagentsbuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic kits comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatmentmonitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
Class 42
DNA analysis services for scientific research purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays
Class 44
DNA screening for medical purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays
Publications
History of USPTO decisions and trademark events.
48 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/28/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/27/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/26/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/26/2021
IUAF
USE AMENDMENT FILED
03/25/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/02/2020
EX5G
SOU EXTENSION 5 GRANTED
10/01/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/30/2020
EXT5
SOU EXTENSION 5 FILED
09/24/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/24/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/27/2020
EX4G
SOU EXTENSION 4 GRANTED
03/25/2020
EXT4
SOU EXTENSION 4 FILED
03/25/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/25/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/28/2019
EX3G
SOU EXTENSION 3 GRANTED
09/26/2019
EXT3
SOU EXTENSION 3 FILED
09/26/2019
EEXT
SOU TEAS EXTENSION RECEIVED
09/26/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/23/2019
EX2G
SOU EXTENSION 2 GRANTED
03/21/2019
EXT2
SOU EXTENSION 2 FILED
03/21/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/21/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2018
EX1G
SOU EXTENSION 1 GRANTED
09/27/2018
EXT1
SOU EXTENSION 1 FILED
09/27/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/05/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/28/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/28/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/30/2018
PUBO
PUBLISHED FOR OPPOSITION
01/30/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/10/2018
ALIE
ASSIGNED TO LIE
12/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/05/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/05/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/05/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/05/2017
DOCK
ASSIGNED TO EXAMINER
12/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2017
NWAP
NEW APPLICATION ENTERED
09/01/2017
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOQUANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.